135 related articles for article (PubMed ID: 7126997)
1. Effects of lysine-vasopressin and oxytocin on central cardiovascular control.
Tran LD; Montastruc JL; Montastruc P
Br J Pharmacol; 1982 Sep; 77(1):69-73. PubMed ID: 7126997
[TBL] [Abstract][Full Text] [Related]
2. Neurohypophysial peptides and central cardiovascular control.
Montastruc JL; Dang Tran L; Montastruc P
Eur Heart J; 1983 Nov; 4 Suppl G():47-50. PubMed ID: 6662121
[TBL] [Abstract][Full Text] [Related]
3. The role of adrenal medulla and neurohypophysis in the central and peripheral cardiovascular effects of neurohypophysial peptides.
Montastruc JL; Dang Tran L
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):299-308. PubMed ID: 6486975
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration of a central hypotensive action of lysine vasopressin in the dog].
Tran LD; Montastruc JL; Montastruc P
C R Seances Acad Sci III; 1981 Oct; 293(5):267-9. PubMed ID: 6796210
[TBL] [Abstract][Full Text] [Related]
5. Reduction of vagal pressor reflexes by neurohypophyseal peptides and related compounds.
Montastruc P; Dang Tran L; Montastruc JL
Eur J Pharmacol; 1985 Nov; 117(3):355-61. PubMed ID: 4076350
[TBL] [Abstract][Full Text] [Related]
6. Central cardiovascular actions of d-tubocurarine and inhibition of the hypotensive effect of clonidine.
Tsoucaris-Kupfer D; Liblau L; Legrand M; Schmitt H
Eur J Pharmacol; 1980 Jul; 65(2-3):301-4. PubMed ID: 7398793
[TBL] [Abstract][Full Text] [Related]
7. Neurohypophysial peptides and central cardiovascular control in the anaesthetized dog.
Montastruc JL; Dang Tran L
Clin Exp Hypertens A; 1984; 6(10-11):1987-91. PubMed ID: 6532583
[No Abstract] [Full Text] [Related]
8. Central cardiovascular effects of acetylcholine in the conscious dog.
Brefel C; Lazartigues E; Tran MA; Gauquelin G; Geelen G; Gharib C; Montastruc JL; Montastruc P; Rascol O
Br J Pharmacol; 1995 Oct; 116(4):2175-82. PubMed ID: 8564246
[TBL] [Abstract][Full Text] [Related]
9. Area postrema lesions augment the pressor activity of centrally administered vasopressin.
Michelini LC; Barnes KL; Ferrario CM
Clin Exp Hypertens A; 1986; 8(7):1107-25. PubMed ID: 3769219
[TBL] [Abstract][Full Text] [Related]
10. Central cardiovascular effects induced by intracisternal PACAP in dogs.
Seki Y; Suzuki Y; Baskaya MK; Saito K; Takayasu M; Shibuya M; Sugita K
Am J Physiol; 1995 Jul; 269(1 Pt 2):H135-9. PubMed ID: 7631841
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-glutamic acid and kainic acid on central cardiovascular control.
Chelly J; Kouyoumdjian JC; Mouillé P; Huchet AM; Schmitt H
Eur J Pharmacol; 1979 Nov; 60(1):91-4. PubMed ID: 520420
[TBL] [Abstract][Full Text] [Related]
12. Central cardiovascular action of penicillin in anaesthetized dogs and rats.
Tsoucaris-Kupfer D; Liblau L; Legrand M; Schmitt H
Neuropharmacology; 1983 Jul; 22(7):903-6. PubMed ID: 6621819
[TBL] [Abstract][Full Text] [Related]
13. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
Feuerstein G; Zerbe RL; Faden AI
J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
[TBL] [Abstract][Full Text] [Related]
14. Centrally mediated cardiovascular effects of nicergoline in the dog compared to those of clonidine.
Lièvre M; Morin MH; Lakhal M; Faucon G
Eur J Pharmacol; 1985 Oct; 117(1):103-7. PubMed ID: 4085539
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of the hypotensive effect of apomorphine].
Montastruc JL; Guiol C
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1176-80. PubMed ID: 6441536
[TBL] [Abstract][Full Text] [Related]
16. Hydroxy analogues of oxytocin and of lysine-vasopressin.
Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs.
Oyama H; Suzuki Y; Satoh S; Kajita Y; Takayasu M; Shibuya M; Sugita K
J Cereb Blood Flow Metab; 1993 Mar; 13(2):285-90. PubMed ID: 8436620
[TBL] [Abstract][Full Text] [Related]
18. Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
Montastruc JL; Guiol C; Tran MA; Lhoste F; Montastruc P
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):92-103. PubMed ID: 4062436
[TBL] [Abstract][Full Text] [Related]
19. Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog.
Montastruc JL; Montastruc P
Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):132-8. PubMed ID: 7387255
[TBL] [Abstract][Full Text] [Related]
20. Hypotension produced by intravenous apomorphine in the anaesthetized dog is not centrally mediated.
Bogaert MG; Buylaert WA; Willems JL
Br J Pharmacol; 1978 Jul; 63(3):481-4. PubMed ID: 667492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
